IL receptor inhibitor Suplatast tosilate, Purity ≥98%

Cat. No.: X23-10-ZQ513

IL receptor inhibitor Suplatast tosilate, Purity ≥98%

Synonym: Suplatast Tosilate; Suplatast tosylate; 94055-76-2; Ipd 1151T; IPD-1151T; Suplatast (Tosilate); Suplatasttosilate; IL receptor inhibitor

  • MDL: MFCD00867604
  • CAS Number: 94055-76-2
  • Compound CID: 71773
Product Size
25 mg; 50 mg; 100 mg; 200 mg
Price
Datasheet
MSDS
Properties
Description
Suplatast tosilate, soluble in DMSO, water and ethanol, blocks the binding of interleukins (cytokines) to their corresponding receptors on the cell surface, thereby inhibiting the downstream signaling pathways.
Molecular Weight
499.6
Molecular Formula
C23H33NO7S2
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 97 mg/mL (194.14 mM); Water: 97 mg/mL (194.14 mM); Ethanol: 97 mg/mL (194.14 mM)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Suplatast tosilate can be used to study its anti-allergic effects and its role in treating allergic diseases.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.